Comparative studies of vertebrate platelet glycoprotein 4 (CD36)

Biomolecules

Volumn 2, Issue 3, 2012, Pages 389-414

  Holmes, Roger S ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Amino acid sequence; CD36; Evolution; Thrombospondin receptor; Vertebrates

Indexed keywords

CD36 ANTIGEN; CYSTEINE; GLYCINE; MEMBRANE PROTEIN; PROLINE; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR BI; SCAVENGER RECEPTOR BII; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; DOWN REGULATION; EXON; GENE EXPRESSION; GENE LOCATION; GENE STRUCTURE; GLYCOSYLATION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PHYLOGENY; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; UPREGULATION; VERTEBRATE;

EID: 85016359800     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom2030389     Document Type: Review

References (88)

1. Oquendo, P.; Hundt, E.; Lawler, J.; Seed, B. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 1989, 58, 95-101.
2. Asch, A.S.; Silbiger, S.; Heimer, E.; Nachman, R.L. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem. Biophys. Res. Commun. 1992, 182, 1208-1217.
3. Navazo, M.D.; Daviet, L.; Savill, J.; Ren, Y.; Leung, L.L.; McGregor, J.L. Identification of a domain (155-183) on CD36 implicated in the phagocytosis of apoptotic neutrophils. J. Biol. Chem. 1996, 271, 15381-15385.
4. Serghides, L.; Crandall, I.; Hull, E.; Kain, K.C. The Plasmodium falciparum-CD36 interaction is modified by a single amino acid substitution in CD36. Blood 1998, 92, 1814-1819.
5. Simantov, R.; Silverstein, R.L. CD36: A critical anti-angiogenic receptor. Front. Biosci. 2003, 8, s874-s882.
6. Adachi, H.; Tsujimoto, M. Endothelial scavenger receptors. Prog. Lipid Res. 2006, 45, 379-404.
7. Collot-Teixeira, S.; Martin, J.; McDermott-Roe, C.; Poston, R.; McGregor, J.L. CD36 and macrophages in atherosclerosis. Cardiovasc. Res. 2007, 75, 468-477.
8. Martin, C.A.; Longman, E.; Wooding, C.; Hoosdally, S.J.; Ali, S.; Aitman, T.J.; Gutmann, D.A.; Freemont, P.S.; Byrne, B.; Linton, K.J. Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteins. Protein Sci. 2007, 16, 2531-2541.
9. Gautam, S.; Banerjee, M. The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus. Mol. Genet. Metab. 2011, 102, 389-398.
10. Ren, Y. Peroxisome proliferator-activator receptor γ: A link between macrophage CD36 and inflammation in malaria infection. PPAR Res. 2012, 2012, 640769.
11. Smith, B.K.; Jain, S.S.; Rimbaud, S.; Dam, A.; Quadrilatero, J.; Ventura-Clapier, R.; Bonen, A.; Holloway, G.P. FAT/CD36 is located on the outer mitochondrial membrane, upstream of long-chain acyl-CoA synthetase, and regulates palmitate oxidation. Biochem. J. 2011, 437, 125-134.
12. Baranova, I.N.; Bocharov, A.V.; Vishnyakova, T.G.; Kurlander, R.; Chen, Z.; Fu, D.; Arias, I.M.; Csako, G.; Patterson, A.P.; Eggerman, T.L. CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells. J. Biol. Chem. 2010, 285, 8492-8506.
13. Park, L.; Wang, G.; Zhou, P.; Zhou, J.; Pitstick, R.; Previti, M.L.; Younkin, L.; Younkin, S.G.; Van Nostrand, W.E.; Cho, S.; et al. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta. Proc. Natl. Acad. Sci. USA 2011, 108, 5063-5068.
14. Martin, C.; Chevrot, M.; Poirier, H.; Passilly-Degrace, P.; Niot, I.; Besnard, P. CD36 as a lipid sensor. Physiol. Behav. 2011, 105, 36-42.
15. Chen, K.; Li, W.; Silverstein, R.L. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Circ. Res. 2008, 102, 1512-1519.
16. Acton, S.; Osgood, D.; Donoghue, M.; Corella, D.; Pocovi, M.; Cenarro, A.; Mozas, P.; Keilty, J.; Squazzo, S.; Woolf, E.A.; et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 1734-1743.
17. Bultel-Brienne, S.; Lestavel, S.; Pilon, A.; Laffont, I.; Tailleux, A.; Fruchart, J.C.; Siest, G.; Clavey, V. Lipid free apolipoprotein E binds to the class B Type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins. J. Biol. Chem. 2002, 277, 36092-36099.
18. Marsche, G.; Zimmermann, R.; Horiuchi, S.; Tandon, N.N.; Sattler, W.; Malle, E. Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein. J. Biol. Chem. 2003, 278, 47562-47570.
19. Connelly, M.A.; Williams, D.L. Scavenger receptor BI: A scavenger receptor with a mission to transport high density lipoprotein lipids. Curr. Opin. Lipid. 2004, 5, 287-295.
20. Kent, A.P.; Stylianou, I.M. Scavenger receptor class B member 1 protein: Hepatic regulation and its effects on lipids, reverse cholesterol transport, and atherosclerosis. Hep. Med.: Evid. Res. 2011, 3, 29-44.
21. Fujita, H.; Takata, Y.; Kono, A.; Tanaka, Y.; Takahashi, T.; Himeno, M.; Kato, K. Isolation and sequencing of a cDNA clone encoding the 85 kDa human lysosomal sialoglycoprotein (hLGP85) in human metastatic pancreas islet tumor cells. Biochem. Biophys. Res. Commun. 1992, 184, 604-611.
22. Ogata, S.; Fukuda, M. Lysosomal targeting of Limp II membrane glycoprotein requires a novel Leu-Ile motif at a particular position in its cytoplasmic tail. J. Biol. Chem. 1994, 269, 5210-5217.
23. Tabuchi, N.; Akasaki, K.; Sasaki, T.; Kanda, N.; Tsuji, H. Identification and characterization of a major lysosomal membrane glycoprotein, LGP85/LIMP II in mouse liver. J. Biochem. 1997, 122, 756-763.
24. Kuronita, T.; Eskelinen, E.L.; Fujita, H.; Saftig, P.; Himeno, M.; Tanaka, Y. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J. Cell Sci. 2002, 115, 4117-4131.
25. Lin, Y.W.; Lin, H.Y.; Tsou, Y.L.; Chitra, E.; Hsiao, K.N.; Shao, H.Y.; Liu, C.C.; Sia, C.; Chong, P.; Chow, Y.H. Human SCARB2-Mediated Entry and Endocytosis of EV71. PLoS One 2012, 7, e30507.
26. Taylor, K.T.; Tang, Y.; Sobieski, D.A.; Lipsky, R.H. Characterization of two alternatively spliced 5′-untranslated exons of the human CD36 gene in different cell types. Gene 1993, 33, 205-212.
27. Fernández-Ruiz, E.; Armesilla, A.L.; Sánchez-Madrid, F.; Vega, M.A. Gene encoding the collagen type I and thrombospondin receptor CD36 is located on chromosome 7q11.2. Genomics 1993, 17, 759-761.
28. Armesilla, A.L.; Vega, M.A. Structural organization of the gene for human CD36 glycoprotein. J. Biol. Chem. 1994, 269, 18985-18991.
29. Rać, M.E.; Safranow, K.; Poncyljusz, W. Molecular basis of human CD36 gene mutations. Mol. Med. 2007, 13, 288-296.
30. Simantov, R.; Febbraio, M.; Silverstein, R.L. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein. Matrix Biol. 2005, 24, 27-34.
31. Seimon, T.A.; Nadolski, M.J.; Liao, X.; Magallon, J.; Nguyen, M.; Feric, N.T.; Koschinsky, M.L.; Harkewicz, R.; Witztum, J.L.; Tsimikas, S.; et al. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab. 2010, 12, 467-482.
32. Nergiz-Unal, R.; Rademakers, T.; Cosemans, J.M.; Heemskerk, J.W. CD36 as a multiple-ligand signaling receptor in atherothrombosis. Cardiovasc. Hematol. Agents Med. Chem. 2011, 9, 42-55.
33. Ruiz-Valasco, N.; Dominguez, A.; Vega, M.A. Statins upregulated CD36 expression in human monocytes, an effect strengthened when combined with PPAR-gamma ligands. Putative contribution of Rho GTPases in statin-induced expression. Biochem. Pharmacol. 2004, 67, 303-313.
34. Liu, H.; Liu, Q.; Lei, H.; Li, X.; Chen, X. Inflammatory stress promotes lipid accumulation in the aorta and liver of SR-A/CD36 double knock-out mice. Mol. Med. Rep. 2010, 3, 1053-1061.
35. Steinbusch, L.K.; Luiken, J.J.; Vlasblom, R.; Chabowski, A.; Hoebers, N.T.; Coumans, W.A.; Vroegrijk, I.O.; Voshol, P.J.; Ouwens, D.M.; Glatz, J.F.; et al. Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. Am. J. Physiol. Endocrinol. Metab. 2011, 301, E618-E627.
36. Kennedy, D.J.; Kashyap, S.R. Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes. Metab. Syndr. Relat. Disord. 2011, 9, 239-245.
37. Lally, J.S.; Jain, S.S.; Han, X.X.; Snook, L.A.; Glatz, J.F.; Luiken, J.J.; McFarlan, J.; Holloway, G.P.; Bonen, A. Caffeine-stimulated fatty acid oxidation is blunted in CD36 null mice. Acta Physiol. 2011, doi:10.1111/j.1748-1716.2011.02396.x.
38. Ma, X.; Bacci, S.; Mlynarski, W.; Gottardo, L.; Soccio, T.; Menzaghi, C.; Iori, E.; Lager, R.A.; Shroff, A.R.; Gervino, E.V.; et al. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum. Mol. Genet. 2004, 13, 2197-2205.
39. Yuasa-Kawase, M.; Masuda, D.; Yamashita, T.; Kawase, R.; Nakaoka, H.; Inagaki, M.; Nakatani, K.; Tsubakio-Yamamoto, K.; Ohama, T.; Matsuyama, A.; et al. Patients with CD36 Deficiency Are Associated with Enhanced Atherosclerotic Cardiovascular Diseases. J. Atheroscler. Thromb. 2011, 19, 263-275.
40. Keller, K.L.; Liang, L.C.; Sakimura, J.; May, D.; van Belle, C.; Breen, C.; Driggin, E.; Tepper, B.J.; Lanzano, P.C.; Deng, L.; et al. Common Variants in the CD36 Gene Are Associated With Oral Fat Perception, Fat Preferences, and Obesity in African Americans. Obesity 2012, doi:10.1038/oby.2011.374.
41. Pain, A.; Urban, B.C.; Kai, O.; Casals-Pascual, C.; Shafi, J.; Marsh, K.; Roberts, D.J. A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 2001, 357, 1502-1503.
42. Omi, K.; Ohashi, J.; Patarapotikul, J.; Hananantachai, H.; Naka, I.; Looareesuwan, S.; Tokunaga, K. CD36 polymorphism is associated with protection from cerebral malaria. Am. J. Hum. Genet. 2003, 72, 364-374.
43. Miquilena-Colina, M.E.; Lima-Cabello, E.; Sánchez-Campos, S.; García-Mediavilla, M.V.; Fernández-Bermejo, M.; Lozano-Rodríguez, T.; Vargas-Castrillón, J.; Buqué, X.; Ochoa, B.; Aspichueta, P.; et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut 2011, 60, 1394-1402.
44. Ashraf, M.Z.; Gupta, N. Scavenger receptors: Implications in atherothrombotic disorders. Int. J. Biochem. Cell Biol. 2011, 43, 697-700.
45. Tandon, N.N.; Lipsky, R.H.; Burgess, W.H.; Jamieson, G.A. Isolation and characterization of platelet glycoprotein IV (CD36). J. Biol. Chem. 1989, 264, 7570-7575.
46. Wyler, B.; Daviet, L.; Bortkiewicz, H.; Bordet, J.C.; McGregor, J.L. Cloning of the cDNA encoding human platelet CD36: Comparison to PCR amplified fragments of monocyte, endothelial and HEL cells. Thromb. Haemost. 1993, 70, 500-505.
47. Tao, N.; Wagner, S.J.; Lublin, D.M. CD36 is palmitoylated on both N-and C-terminal cytoplasmic tails. J. Biol. Chem. 1996, 271, 22315-22320.
48. Chu, L.Y.; Silverstein, R.L. CD36 Ectodomain Phosphorylation Blocks Thrombospondin-1 Binding: Structure-Function Relationships and Regulation by Protein Kinase C. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 760-767.
49. Rasmussen, J.T.; Berglund, L.; Rasmussen, M.S.; Petersen, T.E. Assignment of disulfide bridges in bovine CD36. Eur. J. Biochem. 1998, 257, 488-494.
50. Lewandrowski, U.; Moebius, J.; Walter, U.; Sickmann, A. Elucidation of N-glycosylation sites on human platelet proteins: A glycoproteomic approach. Mol. Cell Proteomics 2006, 5, 226-233.
51. Gupta, R.; Brunak, S. Prediction of glycosylation across the human proteome and the correlation to protein function. Pac. Symp. Biocomput. 2002, 7, 310-322.
52. Lauzier, B.; Merlen, C.; Vaillant, F.; McDuff, J.; Bouchard, B.; Beguin, P.C.; Dolinsky, V.W.; Foisy, S.; Villeneuve, L.R.; Labarthe, F.; et al. Post-translational modifications, a key process in CD36 function: Lessons from the spontaneously hypertensive rat heart. J. Mol. Cell Cardiol. 2011, 51, 99-108.
53. Gaidukov, L.; Nager, A.R.; Xu, S.; Penman, M.; Krieger, M. Glycine dimerization motif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport. J. Biol. Chem. 2011, 286, 18452-18464.
54. Salaun, C.; Greaves, J.; Chamberlain, L.H. The intracellular dynamic of protein palmitoylation. J. Cell Biol. 2010, 191, 1229-1238.
55. Holmes, R.S.; Cox, L.A. Comparative studies of vertebrate scavenger receptor class B type 1 (SCARB1): A high density lipoprotein (HDL) binding protein. Res. Reports Biochem. 2012, 2012, 9-24.
56. Papale, G.A.; Hanson, P.J.; Sahoo, D. Extracellular disulfide bonds support scavenger receptor class B type I-mediated cholesterol transport. Biochemistry 2011, 50, 6245-6254.
57. Yua, M.; Romera, K.A.; Nielanda, T.J.F.; Xua, S.; Saenz-Vashb, V.; Penmana, M.; Yesilaltaya, A.; Carrb, S.A.; Kriegera, M. Exoplasmic cysteine Cys384 of the HDL receptor SR-BI is critical for its sensitivity to a small-molecule inhibitor and normal lipid transport activity. Proc. Natl. Acad. Sci. USA 2011, 108, 12243-12248.
58. Kashiwagi, H.; Tomiyama, Y.; Honda, S.; Kosugi, S.; Shiraga, M.; Nagao, N.; Sekiguchi, S.; Kanayama, Y.; Kurata, Y.; Matsuzawa, Y. Molecular basis of CD36 deficiency. Evidence that a 478C-->T substitution (proline90-->serine) in CD36 cDNA accounts for CD36 deficiency. J. Clin. Invest. 1995, 95, 1040-1046.
59. Yanai, H.; Chiba, H.; Fujiwara, H.; Morimoto, M.; Takahashi, Y.; Hui, S.P.; Fuda, H.; Akita, H.; Kurosawa, T.; Kobayashi, K.; Matsuno, K. Metabolic changes in human CD36 deficiency displayed by glucose loading. Thromb. Haemost. 2001, 86, 995-999.
60. MacArthur, M.W.; Thornton, J.M. Influence of proline residues on protein conformation. J. Mol. Biol. 1991, 218, 397-412.
61. Krieger, A.; Möglich, A.; Kiefhaber, T. Effect of proline and glycine residues on dynamics and barriers of loop formation in polypeptide F. J. Am. Chem. Soc. 2005, 127, 3346-3352.
62. Kay, B.K.; Williamson, M.P.; Sudol, M. The importance of being proline: The interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB. J. 2000, 14, 231-241.
63. Coleman, M.D.; Bass, R.B.; Mehan, R.S.; Falke, J.J. Conserved glycine residues in the cytoplasmic domain of the aspartate receptor play essential roles in kinase coupling and on-off switching. Biochemistry 2005, 44, 7687-7695.
64. Kent, W.J.; Sugnet, C.W.; Furey, T.S. The human genome browser at UCSC. Genome Res. 2003, 12, 994-1006.
65. Armesilla, A.L.; Calvo, D.; Vega, M.A. Structural and functional characterization of the human CD36 gene promoter: Identification of a proximal PEBP2/CBF site. J. Biol. Chem. 1996, 271, 7781-7787.
66. Thierry-Mieg, D.; Thierry-Mieg, J. AceView: A comprehensive cDNA-supported gene and transcripts annotation. Genome Biol. 2006, 7, S12.
67. Sato, O.; Kuriki, C.; Fukui, Y.; Motojima, K. Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands. J. Biol. Chem. 2002, 277, 15703-15711.
68. Olagnier, D.; Lavergne, R.A.; Meunier, E.; Lefèvre, L.; Dardenne, C.; Aubouy, A.; Benoit-Vical, F.; Ryffel, B.; Coste, A.; Berry, A.; et al. Nrf2, a PPARγ alternative pathway to promote CD36 expression on inflammatory macrophages: Implication for malaria. PLoS Pathog. 2011, 7, e1002254.
69. Motojima, K.; Passilly, P.; Peters, J.M.; Gonzalez, F.J.; Latruffe, N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue-and inducer-specific manner. J. Biol. Chem. 1998, 273, 16710-16714.
70. SRF and RSRFC4. Nucleic Acids Res. 1993, 21, 215-221.
71. Cai, R.L. Human CART1, a paired-class homeodomain protein, activates transcription through palindromic binding sites. Biochem. Biophys. Res. Commun. 1998, 250, 305-311.
72. Gómez-Ferrería, M.A.; Rey-Campos, J. Functional domains of FOXJ2. J Mol Biol. 2003, 329, 631-644.
73. He, Y.; Sun, S.; Sha, H.; Liu, Z.; Yang, L.; Xue, Z.; Chen, H.; Qi, L. Emerging roles for XBP1, a sUPeR transcription factor. Gene Expr. 2010, 15, 13-25.
74. Dyczkowski, J.; Vingron, M. Comparative analysis of cell cycle regulated genes in eukaryotes. Genome Inform. 2005, 16, 125-131.
75. Su, A.I.; Wiltshire, T.; Batalov, S.; Lapp, H.; Ching, K.R.; Block, D.; Zhang, J.; Soden, R.; Hayakawa, M.; Kreiman, G.; et al. A gene atlas of the human and mouse protein encoding transcriptomes. Proc. Natl. Acad. Sci. USA 2004, 101, 6062-6067.
76. Eguez, L.; Lee, A.; Chavez, J.A.; Miinea, C.P.; Kane, S.; Lienhard, G.E.; McGraw, T.E. Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab. 2005, 2, 263-272.
77. Thong, F.S.; Bilan, P.J.; Klip, A. The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes 2007, 56, 414-423.
78. Samovski, D.; Su, X.; Xu, Y.; Abumrad, N.A.; Stahl, P.D. Insulin and AMPK regulate fatty acid translocase/CD36 plasma membrane recruitment in cardiomyocytes via RabGAP AS160 and Rab8a Rab GTPase. J. Lipid Res. 2012, [Epub ahead of print].
79. Sano, H.; Kane, S.; Sano, E.; Mîinea, C.P.; Asara, J.M.; Lane, W.S.; Garner, C.W.; Lienhard, G.E. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 2003, 278, 14599-14602.
80. Yuasa, T.; Uchiyama, K.; Ogura, Y.; Kimura, M.; Teshigawara, K.; Hosaka, T.; Tanaka, Y.; Obata, T.; Sano, H.; Kishi, K.; et al. The Rab GTPase-activating protein AS160 as a common regulator of insulin-and Galphaq-mediated intracellular GLUT4 vesicle distribution. Endocr. J. 2009, 56, 345-359.
81. Liani, R.; Halvorsen, B.; Sestili, S.; Handberg, A.; Santilli, F.; Vazzana, N.; Formoso, G.; Aukrust, P.; Davì, G. Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients. Free Radic. Biol. Med. 2012, [Epub ahead of print].
82. Mitchell, R.W.; On, N.H.; Del Bigio, M.R.; Miller, D.W.; Hatch, G.M. Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells. J. Neurochem. 2011, 117, 735-746.
83. Donoghue, P.C.J.; Benton, M.J. Rocks and clocks: Calibrating the tree of life using fossils and molecules. Trends Genet. 2007, 22, 424-431.
84. Bentley, A.A.; Adams, J.C. The evolution of thrombospondins and their ligand-binding activities. Mol. Biol. Evol. 2010, 27, 2187-2197.
85. Altschul, F.; Vyas, V.; Cornfield, A.; Goodin, S.; Ravikumar, T.S.; Rubin, E.H.; Gupta, E. Basic local alignment search tool. J. Mol. Biol. 1997, 215, 403-410.
86. McGuffin, L.J.; Bryson, K.; Jones, D.T. The PSIPRED protein structure prediction server. Bioinform. 2000, 16, 404-405.
87. Hall, T.A. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 1999, 41, 95-99.
88. Felsenstein, J. Confidence limits on phylogenies: An approach using the bootstrap. Evolution 1986, 39, 783-789.